Future Directions for Targeted Therapy - BRAF, NRAS, and more

Hitting the Mark with Targeted Therapy: BRAF, NRAS, CKIT, etc...SullivanПодробнее

BRAF Targeted Therapy - Melanoma Education Symposium, Peter Boasberg MDПодробнее

Targeted Therapy: BRAF and BeyondПодробнее

Targeted Therapy-BRAF Inhibitors and BeyondПодробнее

Targeted Therapies in AMLПодробнее

How is melanoma treated with targeted therapy?Подробнее

Incorporation of BRAF–Targeted Therapy into Neuro Oncology Clinical Practice - Karisa Schreck, M.D.Подробнее

Future Combination Strategies for BRAF-Mutant MelanomaПодробнее

Advances in Therapy for BRAF-mutant MelanomaПодробнее

NRAS mutant melanoma: Targeted therapy, are we there yet?Подробнее

How best to treat NRAS-mutated melanomaПодробнее

Debate: Targeted therapy for RAS/BRAF WT left sided colon cancers - EGFR antibodies are mandatoryПодробнее

Rationale for MEK/BRAF Combinations in MelanomaПодробнее

Vemurafenib and cobimetinib in patients with BRAF-mutated melanomaПодробнее

Options for NRAS-Mutant MelanomaПодробнее

Dr. Sullivan on Targeted Therapy for BRAF-Mutant MelanomaПодробнее

Resistance in BRAF and KRAS Mutant Cancers - by Ryan Corcoran, MD, PhDПодробнее

Melanoma: BRAF/MEK Targeted TherapyПодробнее

Targeting NRAS Mutations in Metastatic MelanomaПодробнее